19 July 2020>: Database Analysis
Systematic Profiling of Alternative Splicing for Sarcoma Patients Reveals Novel Prognostic Biomarkers Associated with Tumor Microenvironment and Immune Cells
Chuan Hu 1ABCEF , Yuanhe Wang 1ABC , Chuan Liu 2DEF , Rui Shen 1DE , Bo Chen 3F , Kang Sun 1B , Huili Rao 4C , Lin Ye 3E , Jianjun Ye 3C , Shaoqi Tian 1ABCDEF*DOI: 10.12659/MSM.924126
Med Sci Monit 2020; 26:e924126
Table 2 Multivariate COX analysis of disease-free survival-related AS events.
Symbol | AS type | HR | Lower.95 | Upper.95 | P value |
---|---|---|---|---|---|
SPIDR | ES | 0.000367 | 1.37E-06 | 0.09814 | 0.005537 |
MMP19 | ES | 0.003436 | 2.96E-05 | 0.398999 | 0.019351 |
PTCH2 | AT | 18.55505 | 1.876145 | 183.5092 | 0.012485 |
BEST3 | AT | 8.490379 | 1.244015 | 57.94666 | 0.029052 |
SLC27A1 | ES | 0.015654 | 0.001242 | 0.197346 | 0.001304 |
IRAK1 | ES | 1.99E-05 | 4.86E-08 | 0.008167 | 0.000421 |
ZNF331 | AP | 3.224539 | 1.09384 | 9.505643 | 0.03379 |
PPRC1 | ES | 418.7191 | 7.698737 | 22773.3 | 0.003066 |
AS – alternative splicing; ES – exon skip; AP – alternate promoter; AT – alternate terminator. |